Results
1
High return on equity, past performance and sound balance sheet.
1 companies
Bioxyne
Market Cap: AU$94.2m
Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan.
BXN
AU$0.043
7D
16.2%
1Y
95.5%